ARDT

Ardent Health Partners, Inc. (ARDT) - Q1 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2025. Ardent Health Partners, Inc. is a leading provider of healthcare services operating 30 acute care hospitals across six states (Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas). The company operates through a joint venture model with academic medical centers and not-for-profit systems. Following its Initial Public Offering (IPO) and corporate conversion in July 2024, the company is now a Delaware corporation listed on the NYSE.

Key Financial Metrics

Note: Adjusted EBITDAR is a non-GAAP measure adding back rent expense payable to REITs.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 4.0% ($58.2 million) year-over-year, driven by a 2.7% increase in adjusted admissions and a 1.2% increase in net patient service revenue per adjusted admission.
• Profitability: Net income attributable to Ardent increased 53.0% to $41.4 million. This was significantly aided by a one-time gain of $21.5 million from insurance recovery proceeds related to a 2023 cybersecurity incident.
• Expense Trends: Salaries and benefits increased to 43.9% of revenue (from 43.2%), primarily due to an $8.8 million increase in equity-based compensation. Supplies expense decreased as a percentage of revenue (17.3% vs 17.9%) due to supply chain optimization.
• Debt Management: Interest expense decreased to $14.2 million (from $19.3 million) following a September 2024 repricing of the Term Loan B Facility, which reduced interest rates by 50 basis points.
• Cash Flow: Net cash used in operating activities was $24.8 million, compared to $14.7 million in the prior year, impacted by changes in working capital and billing collections normalizing post-cybersecurity incident.

Outlook, Risks, and Unusual Items

• Unusual Items: The financial results include a $21.5 million non-operating gain from insurance proceeds related to the 2023 ransomware incident. Management expects the consolidated class action settlement related to this incident to be finalized in August 2025, with payments that will not materially impact financial position.
• Acquisitions: On January 1, 2025, the company acquired 18 urgent care clinics in New Mexico and Oklahoma for $27.5 million. Most of the purchase price was allocated to goodwill.
• Guidance: The filing does not provide specific numerical guidance for the full year 2025. Management notes that historical results are not indicative of future performance due to regulatory and economic uncertainties.
• Risks: Key risks include potential reductions in Medicare/Medicaid reimbursement rates, labor shortages, inflationary pressures on wages and supplies, and the impact of the Ventas Master Lease restrictions. The company also faces ongoing litigation and regulatory audits common in the healthcare industry.

Investor Verification Checklist

• Cybersecurity Impact: Verify the final settlement terms and any remaining liabilities associated with the 2023 ransomware incident and the consolidated class action lawsuit.
• Non-GAAP Reconciliations: Review the reconciliation of Adjusted EBITDA and Adjusted EBITDAR to understand the impact of the $21.5 million insurance gain and the add-back of REIT rent expenses.
• Debt Covenants: Confirm compliance with the Ventas Master Lease covenants (minimum portfolio coverage ratio of 2.2x) and Senior Secured Credit Facility covenants, given the high leverage and lease obligations.
• Equity Compensation: Assess the sustainability of the $9.3 million equity-based compensation expense, which significantly impacted Q1 2025 net income.
• Working Capital: Monitor accounts receivable trends, as the company noted a return to standard billing collections following the cybersecurity disruption in the prior year.